The cause of the malignant blood cancer, multiple myeloma is
unknown, but advances in treatment, including new medications and
stem-cell transplants, are giving patients longer periods of
To continue reading this article, you must login
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.